Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)-Reference-Cited by-同舟云学术

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)

Published:1994-01 Issue:14 Volume:30 Page:2091-2093
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ohtsu A.,Shimada Y.,Yoshida S.,Saito H.,Seki S.,Morise K.,Kurihara M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Chemotherapy of gastrointestinal cancer;Moertel,1977

2. A phase II study of cisplatin in advanced gastric cancer;Beer;Eur J Cancer Clin Oncol,1983

3. Pilot phase II study of cisdiaminedichloroplatinum (II) against metastatic gastric cancers;Miyamoto;Jpn J Clin Oncol,1990

4. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas;Moertel;J Clin Oncol,1986

5. Cis-diamminedichloroplatinum (II): combination chemotherapy and cross-resistance studies with tumors of mice;Schabel;Cancer Treat Rep,1979

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer;Journal of Rural Medicine;2017

2. Global chemotherapy development for gastric cancer;Gastric Cancer;2016-10-07

3. Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells;Oncology Letters;2014-07-22

4. Cancer of the Stomach and Gastroesophageal Junction;Abeloff's Clinical Oncology;2014

5. A Phase III study of combination therapy of the oral fluorinated pyrimidine compound tegafur-uracil (UFT) with low dose cisplatin compared with UFT alone in patients with locally advanced gastric cancer as postoperative adjuvant chemotherapy;Annals of Cancer Research and Therapy;2012